Clinical Trial Update: A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and antiviral activity of two HIV-neutralizing monoclonal antibodies (VRC07-523LS and PGT121.414.LS) during analytic treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PGT121.414.LS
• VRC07-523LS

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV-1-infection | Phase 1 | Status: NOT_YET_RECRUITING